Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer
PaperCitations, authors & open-access status
FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 206 citations, 2017 year and green oa status.
206
Citations
2017
Year
green
OA Status